HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, March 28, 2019 (HealthDay News) -- Providing patients undergoing surgical procedures with an activated charcoal bag for opioid deactivation could increase appropriate opioid disposal, according to a research letter published online March 27 in JAMA Surgery.
Chad M. Brummett, M.D., from Michigan Medicine in Ann Arbor, and colleagues conducted a randomized trial involving 396 opioid-naive patients undergoing an outpatient surgical procedure. Participants were randomly assigned to receive usual care, an educational pamphlet with detailed instructions for locating Drug Enforcement Administration-registered disposal locations, or an activated charcoal bag for opioid deactivation. A total of 208 participants were included in the primary analysis.
The researchers found that 28.6, 33.3, and 57.1 percent of patients receiving usual care, an educational pamphlet, and a charcoal activated bag, respectively, reported disposing opioids. The odds of opioid disposal were 3.8 times higher for patients who received a charcoal bag versus those receiving usual care after adjustment for preoperative patient characteristics. Compared with participants in the other groups, those who received a charcoal bag reported less medication flushing or inappropriate garbage disposal and were significantly less likely to leave the home for disposal.
"Our findings suggest that simple, low-cost interventions (US $2.59 to $6.99/bag), such as in-home deactivation methods, could reduce the number of unused opioids available for diversion," the authors write.
One author disclosed financial ties to the pharmaceutical industry and holds a patent for Peripheral Perineural Dexmedetomidine; a second author disclosed ties to the medical technology industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 27, 2022